These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 14511382)
41. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Lees M; Taylor DJ; Woolley DE Eur J Biochem; 1994 Jul; 223(1):171-7. PubMed ID: 8033891 [TBL] [Abstract][Full Text] [Related]
43. Modulation of the expression of chondroitin sulfate proteoglycan in stimulated human monocytes. Uhlin-Hansen L; Eskeland T; Kolset SO J Biol Chem; 1989 Sep; 264(25):14916-22. PubMed ID: 2768247 [TBL] [Abstract][Full Text] [Related]
44. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor. Rao CN; Mohanam S; Puppala A; Rao JS Biochem Biophys Res Commun; 1999 Feb; 255(1):94-8. PubMed ID: 10082661 [TBL] [Abstract][Full Text] [Related]
45. Calmodulin antagonists increase the expression of membrane-type-1 matrix metalloproteinase in human uterine cervical fibroblasts. Ito A; Yamada M; Sato T; Sanekata K; Sato H; Seiki M; Nagase H; Mori Y Eur J Biochem; 1998 Jan; 251(1-2):353-8. PubMed ID: 9492304 [TBL] [Abstract][Full Text] [Related]
46. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine. Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907 [TBL] [Abstract][Full Text] [Related]
47. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1. Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976 [TBL] [Abstract][Full Text] [Related]
48. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells. Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475 [TBL] [Abstract][Full Text] [Related]
50. Walker 256 cancer cells secrete tissue inhibitor of metalloproteinase-free metalloproteinase-9. Pavlaki M; Giannopoulou E; Niarakis A; Ravazoula P; Aletras AJ Mol Cell Biochem; 2009 Aug; 328(1-2):189-99. PubMed ID: 19330523 [TBL] [Abstract][Full Text] [Related]
51. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes. Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366 [TBL] [Abstract][Full Text] [Related]
52. Dimerization of endogenous MT1-MMP is a regulatory step in the activation of the 72-kDa gelatinase MMP-2 on fibroblasts and fibrosarcoma cells. Ingvarsen S; Madsen DH; Hillig T; Lund LR; Holmbeck K; Behrendt N; Engelholm LH Biol Chem; 2008 Jul; 389(7):943-53. PubMed ID: 18627313 [TBL] [Abstract][Full Text] [Related]
53. Activation of TIMP-2/progelatinase A complex by stromelysin. Miyazaki K; Umenishi F; Funahashi K; Koshikawa N; Yasumitsu H; Umeda M Biochem Biophys Res Commun; 1992 Jun; 185(3):852-9. PubMed ID: 1320876 [TBL] [Abstract][Full Text] [Related]
54. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942 [TBL] [Abstract][Full Text] [Related]
55. Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1). Chen LC; Noelken ME; Nagase H Biochemistry; 1993 Oct; 32(39):10289-95. PubMed ID: 8399171 [TBL] [Abstract][Full Text] [Related]
56. Stepwise activation mechanisms of the precursors of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin). Nagase H; Suzuki K; Enghild JJ; Salvesen G Biomed Biochim Acta; 1991; 50(4-6):749-54. PubMed ID: 1666284 [TBL] [Abstract][Full Text] [Related]
57. Utility of combining MMP-9 enzyme-linked immunosorbent assay and MMP-9 activity assay data to monitor plasma enzyme specific activity. Grierson C; Miller D; LaPan P; Brady J Anal Biochem; 2010 Sep; 404(2):232-4. PubMed ID: 20507826 [TBL] [Abstract][Full Text] [Related]
58. Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases. Santavicca M; Noel A; Angliker H; Stoll I; Segain JP; Anglard P; Chretien M; Seidah N; Basset P Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):953-8. PubMed ID: 8645182 [TBL] [Abstract][Full Text] [Related]
59. Comparative studies of a 92-kDa gelatinolytic metalloproteinase from U937 cells and matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Morodomi T; Suzuki K; Sasaguri Y; Morimatsu M; Nagase H Matrix Suppl; 1992; 1():87-8. PubMed ID: 1480100 [No Abstract] [Full Text] [Related]